Navigation Links
Medarex Announces Initiation of Phase 2 Clinical Trials for the Treatment of Ulcerative Colitis and Rheumatoid Arthritis
Date:5/12/2008

Presentation of Phase 1 Clinical Data of MDX-1100 at Digestive Disease Week

2008

PRINCETON, N.J., May 12 /PRNewswire-FirstCall/ -- Medarex, Inc. (Nasdaq: MEDX) announced today that it has initiated the Phase 2 clinical development program of MDX-1100, a fully human monoclonal antibody that targets CXCL10 (also known as IP-10), in ulcerative colitis (UC) and rheumatoid arthritis (RA). MDX-1100 could potentially treat UC and RA by suppressing the inflammatory process characteristic of these diseases.

"Based on positive safety data in Phase 1 studies, we have initiated patient enrollment in Phase 2 studies that are designed to establish proof-of-concept," said Geoffrey M. Nichol, M.B.Ch.B., Senior Vice President of Product Development at Medarex. "We are optimistic about the broad potential of MDX-1100 to address a range of inflammatory diseases."

Patients in the Phase 2 randomized, double-blind, placebo-controlled, multi-center study in UC will be administered MDX-1100 at 10 mg/kg or placebo every 2 weeks for a total of 4 doses. All patients will have active UC and will continue standard UC therapy during the trial. The trial is expected to enroll 106 patients at multiple sites internationally. The primary endpoint of the study is the response rate at 8 weeks. Clinical response is based on the Mayo score, a composite endpoint that assesses stool frequency and the amount of bloody stool per day as recorded in a patient diary, physician global assessment and the assessment of colon mucosal inflammation ascertained by endoscopy.

Patients in the Phase 2 randomized, double-blind, placebo-controlled, multi-center study in RA will be administered MDX-1100 at 10 mg/kg or placebo every 2
'/>"/>

SOURCE Medarex, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Medarex Announces Allowance of Investigational New Drug Applications for Wholly Owned Fully Human Anti-CD19 Antibody, MDX-1342
2. Medarex to Receive Milestone Payment from Amgen
3. Medarex Announces Ipilimumab Program Continues to Move Forward
4. Medarex Reports Interim Data from Ongoing Ipilimumab Combination Phase 1 Studies in Prostate Cancer at American Association for Cancer Research Meeting
5. Medarex Announces Presentations at Annual Meeting of the American Society of Clinical Oncology
6. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
7. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
8. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
9. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
10. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
11. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2014)... Sept. 19, 2014  The board of directors of ... quarterly cash dividend of $0.42 per share.  ... to stockholders of record at the close of business ... is a global, research-based biopharmaceutical company formed in 2013 ... use its expertise, dedicated people and unique approach to ...
(Date:9/19/2014)... Sept. 19, 2014  4WEB Medical announces the formal ... and ankle osteotomy implants on the market today ... annual meeting in Chicago .  The ... a surgeon,s osteotomy needs with 74 size options included in ... offerings of only 15 to 18 implant sizes, which ...
(Date:9/19/2014)... 2014 The American Association for Homecare (AAHomecare) ... Manufacturing has joined the AAHomecare Corporate Partner Program. ... have been actively involved in AAHomecare for much ... quickly grown into a major global manufacturer of home ... AAHomecare to increase efforts on behalf of the HME ...
Breaking Medicine Technology:4WEB Medical Unveils 3D-Printed Osteotomy Truss System 2Drive Medical Design & Manufacturing Joins AAHomecare Corporate Partner Program 2
... AccessClosure, Inc., the market leader in extravascular closure devices, ... distribute the Bengal Radial Compression Band in the United ... join the Mynx™ Vascular Closure Device in AccessClosure,s portfolio ... crucial to offer a solution for our customers who ...
... Escalon Medical Corp. (Nasdaq: ESMC ) ... 30, 2010.   Consolidated product revenue from ... $30,657,000, compared with $30,600,000 in the prior fiscal year. ... Drew and Trek business units, which increased approximately 7.3% ...
Cached Medicine Technology:AccessClosure Announces Distribution Agreement for Radial Compression Band 2Escalon® Reports Fiscal 2010 Results 2Escalon® Reports Fiscal 2010 Results 3Escalon® Reports Fiscal 2010 Results 4Escalon® Reports Fiscal 2010 Results 5Escalon® Reports Fiscal 2010 Results 6Escalon® Reports Fiscal 2010 Results 7
(Date:9/20/2014)... 20, 2014 Plumbing construction services ... of 5, indicating a moderately favorable purchasing environment for ... reflects current and future pricing trends that will limit ... Other factors that negatively affect buyer power are a ... and the moderate switching costs. Buyers benefit, however, from ...
(Date:9/20/2014)... RBSEO Services, which has occupied a top ... it provides an affordable website SEO (Search Engine Optimization) ... would benefit those new and old businesses struggling to ... to pay a big amount for their website promotion. ... in top search results for their business keywords and ...
(Date:9/20/2014)... 2014 The first federal bellwether trial ... its third week in the U.S. District Court, Northern ... documents indicate that the week opened in the ... a DePuy Orthopaedics vice president, who discussed the clinical ... Pinnacle hip replacement. According to Reuters, the executive stated ...
(Date:9/20/2014)... September 20, 2014 The children of ... balanced and active play they need. An empty lot ... - Lakeview Campus was transformed into a kid-designed playspace ... 150+ volunteers from Branches (@BranchesFL), ESPN (@TeamESPN), Disney (@CitizenDisney), ... KaBOOM! believes a playground is more than a playground. ...
(Date:9/19/2014)... 2014 “Copay coupons,” a drug manufacturer ... drugs among patients with prescription drug coverage, may now ... new report from the Department of Health and ... anti-kickback laws prohibit suppliers from offering side-payments to increase ... government. , The report highlights that two recent surveys, ...
Breaking Medicine News(10 mins):Health News:Plumbing Construction Services Procurement Category Market Research Report from IBISWorld Has Been Updated 2Health News:Plumbing Construction Services Procurement Category Market Research Report from IBISWorld Has Been Updated 3Health News:Plumbing Construction Services Procurement Category Market Research Report from IBISWorld Has Been Updated 4Health News:RBSEO Services Announces Affordable Website SEO Service at Only $175 2Health News:Third Week of DePuy Pinnacle Hip Lawsuit Trial Focuses on Clinical Testing of Metal-on-Metal Hip Implant, Wright & Schulte LLC Reports 2Health News:Third Week of DePuy Pinnacle Hip Lawsuit Trial Focuses on Clinical Testing of Metal-on-Metal Hip Implant, Wright & Schulte LLC Reports 3Health News:Third Week of DePuy Pinnacle Hip Lawsuit Trial Focuses on Clinical Testing of Metal-on-Metal Hip Implant, Wright & Schulte LLC Reports 4Health News:Volunteers Improve Miami Kids’ Lives and Futures with Play 2Health News:Volunteers Improve Miami Kids’ Lives and Futures with Play 3Health News:Volunteers Improve Miami Kids’ Lives and Futures with Play 4Health News:PCMA: New OIG Report Cites Drug Manufacturer“Copay Coupon” Use in Medicare Part D 2
... , WEDNESDAY, Nov. 17 (HealthDay News) -- Resistance ... than aerobic exercise and offers other cardiovascular benefits, finds ... University in Boone, N.C., compared blood vessel (vascular) responses ... 10 repetitions of eight resistance exercises and 30 minutes ...
... News) -- The U.S. Food and Drug Administration on Wednesday ... illegal. In warning letters to the companies, the agency ... "unsafe food additive," and the companies risked further action, including ... for the claim that the addition of caffeine to these ...
... approaches to targeting diseases such as cancer has been announced ... announced the potential for more targeted treatments following their identification ... of a human cell. The research teams from Germany ... Online Publication on Nature Cell Biology ,s website. ...
... have a chance to fight health problems if they ... to medications costs thousands of lives and billions of ... to the New England Healthcare Institute. Now, researchers at ... that is three times more effective than previously studied ...
... Addiction has launched a new service for its readers: ... each monthly issue, article by article, in bite-sized chunks. To ... of the functions of a scholarly journal is to make ... and clearly as possible. We think that article titles and ...
... (HealthDay News) -- The structure of the placenta influences the ... their study, the investigators found that babies grow twice as ... and that the difference in growth rate is due to ... the mother and baby. The more intimate the connection ...
Cached Medicine News:Health News:Resistance Exercise May Offer Different Cardio Benefits 2Health News:FDA Cracks Down on Caffeinated Alcohol Drinks 2Health News:FDA Cracks Down on Caffeinated Alcohol Drinks 3Health News:Scientists announce new advance with potential for future cancer targeting 2Health News:Researchers fight America's 'other drug problem' 2Health News:Gestational Period Depends on Structure of Placenta: Research 2
Malis Curette, bayonet, titanium handle, stainless steel shaft, working distance 102 mm, length 203 mm....
Cobb Curettes, reverse angled, 11"....
Castroviejo "HM" Micro Needle Holder with Tungsten-Carbide Inserts, with catch. Serrated....
Barraquer needle holder, curved, delicate....
Medicine Products: